| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.53B | 55.98B | 50.97B | 49.31B | 46.71B | 50.10B |
| Gross Profit | 57.20B | 53.62B | 49.77B | 48.89B | 46.42B | 50.10B |
| EBITDA | 10.48B | 14.13B | 11.12B | 10.56B | 10.09B | 9.48B |
| Net Income | 8.80B | 7.94B | 6.26B | 5.83B | 5.01B | 5.21B |
Balance Sheet | ||||||
| Total Assets | 3.02T | 2.98T | 2.93T | 2.88T | 2.86T | 2.67T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 349.39B | 439.56B | 510.74B | 590.65B | 455.12B |
| Total Debt | 98.58B | 99.84B | 94.55B | 161.03B | 222.29B | 316.06B |
| Total Liabilities | 2.87T | 2.83T | 2.78T | 2.72T | 2.70T | 2.51T |
| Stockholders Equity | 156.96B | 153.51B | 156.92B | 153.66B | 159.39B | 160.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.18B | -44.16B | -52.34B | 183.86B | 4.48B |
| Operating Cash Flow | 0.00 | 11.30B | -42.59B | -50.07B | 188.08B | 6.84B |
| Investing Cash Flow | 0.00 | -106.59B | -25.08B | -28.55B | -48.79B | -116.87B |
| Financing Cash Flow | 0.00 | -1.93B | -5.26B | -2.76B | -4.10B | 364.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥122.09B | 8.48 | ― | 2.71% | 15.37% | 35.08% | |
75 Outperform | ¥172.02B | 7.55 | ― | 2.29% | 13.93% | 54.44% | |
72 Outperform | ¥164.58B | 8.04 | 3.68% | 2.26% | 9.34% | 20.61% | |
69 Neutral | ¥102.19B | 6.66 | ― | 2.46% | 9.12% | 43.43% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥176.69B | 9.13 | ― | 2.23% | 29.06% | 40.95% | |
65 Neutral | ¥128.14B | 9.42 | ― | 0.58% | 15.03% | 16.66% |